Found: 36
Select item for more details and to access through your institution.
The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 20, p. 5080, doi. 10.3390/ijms20205080
- By:
- Publication type:
- Article
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 11, p. 2754, doi. 10.3390/ijms20112754
- By:
- Publication type:
- Article
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA. LI. CA centres.
- Published in:
- Liver International, 2013, v. 33, n. 9, p. 1420, doi. 10.1111/liv.12208
- By:
- Publication type:
- Article
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C.
- Published in:
- Liver International, 2013, v. 33, n. 1, p. 94, doi. 10.1111/liv.12031
- By:
- Publication type:
- Article
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID‐19 patient.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 4, p. 1940, doi. 10.1002/jmv.26803
- By:
- Publication type:
- Article
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.
- Published in:
- Journal of Medical Virology, 2016, v. 88, n. 5, p. 843, doi. 10.1002/jmv.24399
- By:
- Publication type:
- Article
A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 389, doi. 10.3390/vaccines9040389
- By:
- Publication type:
- Article
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma.
- Published in:
- JAMA Surgery, 2024, v. 159, n. 8, p. 881, doi. 10.1001/jamasurg.2024.1184
- By:
- Publication type:
- Article
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.875072
- By:
- Publication type:
- Article
The role of anti-core antibody response in the detection of occult hepatitis B virus infection.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2010, v. 48, n. 1, p. 23, doi. 10.1515/CCLM.2010.002
- By:
- Publication type:
- Article
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056991
- By:
- Publication type:
- Article
Focal Adhesion Kinase (FAK) Mediates the Induction of Pro-Oncogenic and Fibrogenic Phenotypes in Hepatitis C Virus (HCV)-Infected Cells.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0044147
- By:
- Publication type:
- Article
Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032493
- By:
- Publication type:
- Article
Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0017232
- By:
- Publication type:
- Article
Interferon (IFN)--γ--Inducible Protein--10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN-α2a and Ribavirin for Chronic Hepatitis C Virus Infection.
- Published in:
- Journal of Infectious Diseases, 2006, v. 194, n. 7, p. 895
- By:
- Publication type:
- Article
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1589, doi. 10.1007/s00262-020-02561-4
- By:
- Publication type:
- Article
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.00849
- By:
- Publication type:
- Article
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1673, doi. 10.3390/cancers13071673
- By:
- Publication type:
- Article
Predictors of non‐transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.
- Published in:
- Liver International, 2023, v. 43, n. 12, p. 2762, doi. 10.1111/liv.15719
- By:
- Publication type:
- Article
Immune landscape of hepatocellular carcinoma microenvironment: Implications for prognosis and therapeutic applications.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1608, doi. 10.1111/liv.14192
- By:
- Publication type:
- Article
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 371, doi. 10.1111/liv.13979
- By:
- Publication type:
- Article
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.
- Published in:
- Liver International, 2017, v. 37, n. 8, p. 1157, doi. 10.1111/liv.13357
- By:
- Publication type:
- Article
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.
- Published in:
- Liver International, 2015, v. 35, n. 8, p. 2001, doi. 10.1111/liv.12778
- By:
- Publication type:
- Article
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics.
- Published in:
- Abdominal Radiology, 2021, v. 46, n. 10, p. 4689, doi. 10.1007/s00261-021-03183-9
- By:
- Publication type:
- Article
Pattern of macrovascular invasion in hepatocellular carcinoma.
- Published in:
- European Journal of Clinical Investigation, 2021, v. 51, n. 7, p. 1, doi. 10.1111/eci.13542
- By:
- Publication type:
- Article
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection.
- Published in:
- Biomedicines, 2022, v. 10, n. 6, p. 1224, doi. 10.3390/biomedicines10061224
- By:
- Publication type:
- Article
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter.
- Published in:
- International Journal of Biological Markers, 2021, v. 36, n. 1, p. 54, doi. 10.1177/1724600821996372
- By:
- Publication type:
- Article
Unraveling the Multifaceted Nature of CD8 T Cell Exhaustion Provides the Molecular Basis for Therapeutic T Cell Reconstitution in Chronic Hepatitis B and C.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2563, doi. 10.3390/cells10102563
- By:
- Publication type:
- Article
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 3, p. 614, doi. 10.3390/cells10030614
- By:
- Publication type:
- Article
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 14, p. 2150, doi. 10.1002/cncr.28706
- By:
- Publication type:
- Article
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.942341
- By:
- Publication type:
- Article
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma.
- Published in:
- Liver Cancer International, 2021, v. 2, n. 2, p. 45, doi. 10.1002/lci2.33
- By:
- Publication type:
- Article
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.563249
- By:
- Publication type:
- Article
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00192
- By:
- Publication type:
- Article
Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infection.
- Published in:
- European Journal of Immunology, 2004, v. 34, n. 11, p. 3208, doi. 10.1002/eji.200424889
- By:
- Publication type:
- Article